Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus.
Todoerti M, Favalli EG, Iannone F, Olivieri I, Benucci M, Cauli A, Mathieu A, Santo L, Minisola G, Lapadula G, Bucci R, Gremese E, Caporali R. Todoerti M, et al. Among authors: bucci r. Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii42-vii53. doi: 10.1093/rheumatology/key195. Rheumatology (Oxford). 2018. PMID: 30289539 Free article. Review.
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: bucci r. Semin Arthritis Rheum. 2017 Aug;47(1):108-114. doi: 10.1016/j.semarthrit.2017.01.008. Epub 2017 Jan 18. Semin Arthritis Rheum. 2017. PMID: 28216195
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
Iannone F, Santo L, Bucci R, Semeraro A, Carlino G, Paoletti F, Quarta L, Leucci P, Zuccaro C, Marsico A, Scioscia C, D'Onofrio F, Mazzotta D, Muratore M, Cantatore FP, Lapadula G. Iannone F, et al. Among authors: bucci r. Clin Rheumatol. 2018 Mar;37(3):667-675. doi: 10.1007/s10067-018-3989-2. Epub 2018 Feb 7. Clin Rheumatol. 2018. PMID: 29411182
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.
Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R. Favalli EG, et al. Among authors: bucci r. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):19-26. Epub 2019 May 10. Clin Exp Rheumatol. 2020. PMID: 31074721
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study.
Serban T, Allara R, Azzolini V, Bellintani C, Belloli L, Belai Beyene N, Bucci R, Caporali R, Cappelli A, Corbelli V, DE Gennaro F, Fusaro E, Giusti A, Govoni M, Magnani L, Manzo C, Romano C, Rossini M, Santilli D, Saviola G, Sinigaglia L, Bianchi G; MARTE study group. Serban T, et al. Among authors: bucci r. Minerva Med. 2021 Apr;112(2):246-254. doi: 10.23736/S0026-4806.21.06902-0. Epub 2021 Feb 8. Minerva Med. 2021. PMID: 33555152
Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
Iannone F, Santo L, Bucci R, Semeraro A, Carlino G, Paoletti F, Quarta L, Leucci P, Zuccaro C, Marsico A, Scioscia C, D'Onofrio F, Mazzotta D, Muratore M, Cantatore FP, Lapadula G. Iannone F, et al. Among authors: bucci r. Clin Rheumatol. 2018 Apr;37(4):1141-1142. doi: 10.1007/s10067-018-4033-2. Clin Rheumatol. 2018. PMID: 29464525
Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F, Semeraro A, Carlino G, Santo L, Bucci R, Quarta L, Maruotti N, Zuccaro C, Marsico A, Falappone PCF, Mazzotta D, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: bucci r. Clin Drug Investig. 2019 Jun;39(6):565-575. doi: 10.1007/s40261-019-00782-9. Clin Drug Investig. 2019. PMID: 30941736
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
Carlino G, Fornaro M, Santo L, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Zuccaro C, Falappone PC, Mazzotta D, Cantatore FP, Muratore M, Iannone F. Carlino G, et al. Among authors: bucci r. Reumatismo. 2019 Apr 1;71(1):24-30. doi: 10.4081/reumatismo.2019.1154. Reumatismo. 2019. PMID: 30932440 Free article.
314 results